In ovarian cancer, we reported elevated Rac1 and Cdc42 protein levels in high grade vs. low grade tumors [23] and elevated mRNA expression of a constitutively active splice variant Rac1b in low grade ovarian tumors [23]. This evidence concerns the gene RAC1 and ovarian cancer.